The neutralized study of anti-human TNF-α monoclonal antibody on the TNF-α in sera of the psoriatic patients
Jian Wang
Abstract
Jian Wang
Abstract
Objective:To study the neutralization effect of anti-human TNF-α monoclonal antibody on the TNF-α in sera of the psoriatic patients. Methods:We used sandwich ELISA to detect the concentrations of TNF-α in sera of healthy volunteers and patients before and after neutralization with antibody. L929 cells were Used to detect the bioactivities of TNF-α in sera of healthy volunteers and patients before and after neutralization with antibody. Results:The concentrations of TNF-α in sera of healthy volunteers and patients were(3.146±6.184) pg/ml and(62.723±38.379) pg/ml respectively;their bioactivities were(6.817±5.086) % and(57.498±9.125)% respectively. After neutralization with antibody, the concentrations of TNF-α of patients were(0.503±1.178)pg/ml, and the bioactivities of TNF-α of patients were(25.378±14.863)%. Conclusions:We can find that the concentrations and bioactivities of TNF-α in sera of patients were elevated, and anti-human TNF-α monoclonal antibody can well neutralize the concentrations and bioactivities of TNF-α in psoriatic patients’ sera.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the neutralization effect of anti-human TNF-α monoclonal antibody on the TNF-α in sera of the psoriatic patients. Methods:We used sandwich ELISA to detect the concentrations of TNF-α in sera of healthy volunteers and patients before and after neutralization with antibody. L929 cells were Used to detect the bioactivities of TNF-α in sera of healthy volunteers and patients before and after neutralization with antibody. Results:The concentrations of TNF-α in sera of healthy volunteers and patients were(3.146±6.184) pg/ml and(62.723±38.379) pg/ml respectively;their bioactivities were(6.817±5.086) % and(57.498±9.125)% respectively. After neutralization with antibody, the concentrations of TNF-α of patients were(0.503±1.178)pg/ml, and the bioactivities of TNF-α of patients were(25.378±14.863)%. Conclusions:We can find that the concentrations and bioactivities of TNF-α in sera of patients were elevated, and anti-human TNF-α monoclonal antibody can well neutralize the concentrations and bioactivities of TNF-α in psoriatic patients’ sera.
Key concepts: Neutralization, Monoclonal antibody, Tumor necrosis factor alpha, Antibody, Medicine, Monoclonal, Immunology